Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B

doi:10.3748/wjg.v22.i18.4529

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7991)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

540

WORD

214

HTML

3605

Figures (1-4)

268

Tables (1-4)

208

Sum=4835

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1095

Download

2061

Sum=3156

May 14, 2016 (publication date) through Jan 5, 2025

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. May 14, 2016; 22(18): 4529-4537
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4529

Full Size Figure Download Figure

Figure 4 Correlation of serum interleukin-38, Th1- and Th2-type cytokines levels. A-E: Serum IL-38 levels correlated with serum IL-6 levels in patients with CHB during LdT treatment at baseline, and at 12, 24, 36, and 52 wk, respectively; F-H: Serum IL-38 levels correlated with serum IL-12 levels in patients with CHB during LdT treatment at 24, 36, and 52 wk, respectively. IL-38: Interleukin-38; CHB: Chronic hepatitis B; LdT: Telbivudine.

Citation: Wang HJ, Jiang YF, Wang XR, Zhang ML, Gao PJ. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B. World J Gastroenterol 2016; 22(18): 4529-4537
URL: https://www.wjgnet.com/1007-9327/full/v22/i18/4529.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i18.4529